Rachel Johns

Rachel Johns is the Executive Director of Analytics, Formulations, and QC at Avidity Biosciences, Inc. Rachel has a background in bioengineering with a Ph.D. from the University of Washington. Rachel has extensive experience in research and development, specializing in siRNA delivery systems and formulation development. Prior to their current role, Rachel held various positions at Marina Biotech and PATH, where Rachel optimized amplification of HIV gene and developed assays for low-resource settings. Throughout their career, Rachel has demonstrated strong leadership skills, managing research groups and mentoring students.